Motif 316 (n=51)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A6NKT7 | RGPD3 | S1232 | ochoa | RanBP2-like and GRIP domain-containing protein 3 | None |
O14715 | RGPD8 | S1231 | ochoa | RANBP2-like and GRIP domain-containing protein 8 (Ran-binding protein 2-like 3) (RanBP2-like 3) (RanBP2L3) | None |
O60264 | SMARCA5 | S755 | ochoa | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SMARCA5) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H) | ATPase that possesses intrinsic ATP-dependent nucleosome-remodeling activity (PubMed:12972596, PubMed:28801535). Catalytic subunit of ISWI chromatin-remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair; this may require intact histone H4 tails (PubMed:10880450, PubMed:12198550, PubMed:12434153, PubMed:12972596, PubMed:23911928, PubMed:28801535). Within the ISWI chromatin-remodeling complexes, slides edge- and center-positioned histone octamers away from their original location on the DNA template (PubMed:28801535). Catalytic activity and histone octamer sliding propensity is regulated and determined by components of the ISWI chromatin-remodeling complexes (PubMed:28801535). The BAZ1A/ACF1-, BAZ1B/WSTF-, BAZ2A/TIP5- and BAZ2B-containing ISWI chromatin-remodeling complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template in an ATP-dependent manner (PubMed:14759371, PubMed:15543136, PubMed:28801535). The CECR2- and RSF1-containing ISWI chromatin-remodeling complexes do not have the ability to slide mononucleosomes to the center of a DNA template (PubMed:28801535). Binds to core histones together with RSF1, and is required for the assembly of regular nucleosome arrays by the RSF-5 ISWI chromatin-remodeling complex (PubMed:12972596). Involved in DNA replication and together with BAZ1A/ACF1 is required for replication of pericentric heterochromatin in S-phase (PubMed:12434153). Probably plays a role in repression of RNA polymerase I dependent transcription of the rDNA locus, through the recruitment of the SIN3/HDAC1 corepressor complex to the rDNA promoter (By similarity). Essential component of the WICH-5 ISWI chromatin-remodeling complex (also called the WICH complex), a chromatin-remodeling complex that mobilizes nucleosomes and reconfigures irregular chromatin to a regular nucleosomal array structure (PubMed:11980720, PubMed:15543136). The WICH-5 ISWI chromatin-remodeling complex regulates the transcription of various genes, has a role in RNA polymerase I transcription (By similarity). Within the B-WICH complex has a role in RNA polymerase III transcription (PubMed:16603771). Mediates the histone H2AX phosphorylation at 'Tyr-142', and is involved in the maintenance of chromatin structures during DNA replication processes (By similarity). Essential component of NoRC-5 ISWI chromatin-remodeling complex, a complex that mediates silencing of a fraction of rDNA by recruiting histone-modifying enzymes and DNA methyltransferases, leading to heterochromatin formation and transcriptional silencing (By similarity). {ECO:0000250|UniProtKB:Q91ZW3, ECO:0000269|PubMed:10880450, ECO:0000269|PubMed:11980720, ECO:0000269|PubMed:12198550, ECO:0000269|PubMed:12434153, ECO:0000269|PubMed:12972596, ECO:0000269|PubMed:14759371, ECO:0000269|PubMed:15543136, ECO:0000269|PubMed:16603771, ECO:0000269|PubMed:23911928, ECO:0000269|PubMed:28801535}. |
O75112 | LDB3 | S505 | ochoa | LIM domain-binding protein 3 (Protein cypher) (Z-band alternatively spliced PDZ-motif protein) | May function as an adapter in striated muscle to couple protein kinase C-mediated signaling via its LIM domains to the cytoskeleton. {ECO:0000305}. |
O75962 | TRIO | S2506 | ochoa | Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein) | Guanine nucleotide exchange factor (GEF) for RHOA and RAC1 GTPases (PubMed:22155786, PubMed:27418539, PubMed:8643598). Involved in coordinating actin remodeling, which is necessary for cell migration and growth (PubMed:10341202, PubMed:22155786). Plays a key role in the regulation of neurite outgrowth and lamellipodia formation (PubMed:32109419). In developing hippocampal neurons, limits dendrite formation, without affecting the establishment of axon polarity. Once dendrites are formed, involved in the control of synaptic function by regulating the endocytosis of AMPA-selective glutamate receptors (AMPARs) at CA1 excitatory synapses (By similarity). May act as a regulator of adipogenesis (By similarity). {ECO:0000250|UniProtKB:F1M0Z1, ECO:0000269|PubMed:10341202, ECO:0000269|PubMed:22155786, ECO:0000269|PubMed:27418539, ECO:0000269|PubMed:32109419, ECO:0000269|PubMed:8643598}. |
P09972 | ALDOC | S45 | ochoa | Fructose-bisphosphate aldolase C (EC 4.1.2.13) (Brain-type aldolase) | None |
P0DJD0 | RGPD1 | S1216 | ochoa | RANBP2-like and GRIP domain-containing protein 1 (Ran-binding protein 2-like 6) (RanBP2-like 6) (RanBP2L6) | None |
P0DJD1 | RGPD2 | S1224 | ochoa | RANBP2-like and GRIP domain-containing protein 2 (Ran-binding protein 2-like 2) (RanBP2-like 2) (RanBP2L2) | None |
P20290 | BTF3 | S30 | ochoa | Transcription factor BTF3 (Nascent polypeptide-associated complex subunit beta) (NAC-beta) (RNA polymerase B transcription factor 3) | When associated with NACA, prevents inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum (ER). Binds to nascent polypeptide chains as they emerge from the ribosome and blocks their interaction with the signal recognition particle (SRP), which normally targets nascent secretory peptides to the ER. BTF3 is also a general transcription factor that can form a stable complex with RNA polymerase II. Required for the initiation of transcription. {ECO:0000269|PubMed:10982809}. |
P25685 | DNAJB1 | S149 | psp | DnaJ homolog subfamily B member 1 (DnaJ protein homolog 1) (Heat shock 40 kDa protein 1) (HSP40) (Heat shock protein 40) (Human DnaJ protein 1) (hDj-1) | Interacts with HSP70 and can stimulate its ATPase activity. Stimulates the association between HSC70 and HIP. Negatively regulates heat shock-induced HSF1 transcriptional activity during the attenuation and recovery phase period of the heat shock response (PubMed:9499401). Stimulates ATP hydrolysis and the folding of unfolded proteins mediated by HSPA1A/B (in vitro) (PubMed:24318877). {ECO:0000269|PubMed:24318877, ECO:0000269|PubMed:9499401}. |
P26045 | PTPN3 | S425 | ochoa | Tyrosine-protein phosphatase non-receptor type 3 (EC 3.1.3.48) (Protein-tyrosine phosphatase H1) (PTP-H1) | May act at junctions between the membrane and the cytoskeleton. Possesses tyrosine phosphatase activity. |
P26639 | TARS1 | S110 | ochoa | Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1) | Catalyzes the attachment of threonine to tRNA(Thr) in a two-step reaction: threonine is first activated by ATP to form Thr-AMP and then transferred to the acceptor end of tRNA(Thr) (PubMed:25824639, PubMed:31374204). Also edits incorrectly charged tRNA(Thr) via its editing domain, at the post-transfer stage (By similarity). {ECO:0000250|UniProtKB:Q9D0R2, ECO:0000269|PubMed:25824639, ECO:0000269|PubMed:31374204}. |
P28370 | SMARCA1 | S770 | ochoa | SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 1 (SMARCA1) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A1) (EC 3.6.4.-) (Global transcription activator SNF2L1) (Nucleosome-remodeling factor subunit SNF2L) (SNF2L) (SNF2 related chromatin remodeling ATPase 1) | [Isoform 1]: ATPase that possesses intrinsic ATP-dependent chromatin-remodeling activity (PubMed:14609955, PubMed:15310751, PubMed:15640247, PubMed:28801535). ATPase activity is substrate-dependent, and is increased when nucleosomes are the substrate, but is also catalytically active when DNA alone is the substrate (PubMed:14609955, PubMed:15310751, PubMed:15640247). Catalytic subunit of ISWI chromatin-remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:14609955, PubMed:15310751, PubMed:15640247, PubMed:28801535). Within the ISWI chromatin-remodeling complexes, slides edge- and center-positioned histone octamers away from their original location on the DNA template (PubMed:28801535). Catalytic activity and histone octamer sliding propensity is regulated and determined by components of the ISWI chromatin-remodeling complexes (PubMed:28801535). The BAZ1A-, BAZ1B-, BAZ2A- and BAZ2B-containing ISWI chromatin-remodeling complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template (PubMed:28801535). The CECR2- and RSF1-containing ISWI chromatin-remodeling complexes do not have the ability to slide mononucleosomes to the center of a DNA template (PubMed:28801535). Within the NURF-1 and CERF-1 ISWI chromatin remodeling complexes, nucleosomes are the preferred substrate for its ATPase activity (PubMed:14609955, PubMed:15640247). Within the NURF-1 ISWI chromatin-remodeling complex, binds to the promoters of En1 and En2 to positively regulate their expression and promote brain development (PubMed:14609955). May promote neurite outgrowth (PubMed:14609955). May be involved in the development of luteal cells (PubMed:16740656). Facilitates nucleosome assembly during DNA replication, ensuring replication fork progression and genomic stability by preventing replication stress and nascent DNA gaps (PubMed:39413208). {ECO:0000269|PubMed:14609955, ECO:0000269|PubMed:15310751, ECO:0000269|PubMed:15640247, ECO:0000269|PubMed:16740656, ECO:0000269|PubMed:28801535, ECO:0000269|PubMed:39413208}.; FUNCTION: [Isoform 2]: Catalytically inactive when either DNA or nucleosomes are the substrate and does not possess chromatin-remodeling activity (PubMed:15310751, PubMed:28801535). Acts as a negative regulator of chromatin remodelers by generating inactive complexes (PubMed:15310751). {ECO:0000269|PubMed:15310751, ECO:0000269|PubMed:28801535}. |
P29274 | ADORA2A | S329 | ochoa | Adenosine receptor A2a | Receptor for adenosine (By similarity). The activity of this receptor is mediated by G proteins which activate adenylyl cyclase (By similarity). {ECO:0000250|UniProtKB:P11617}. |
P31323 | PRKAR2B | T69 | ochoa | cAMP-dependent protein kinase type II-beta regulatory subunit | Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells. Type II regulatory chains mediate membrane association by binding to anchoring proteins, including the MAP2 kinase. |
P49792 | RANBP2 | S2207 | ochoa | E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270) | E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2 conjugation by UBE2I (PubMed:11792325, PubMed:12032081, PubMed:15378033, PubMed:15931224, PubMed:22194619). Involved in transport factor (Ran-GTP, karyopherin)-mediated protein import via the F-G repeat-containing domain which acts as a docking site for substrates (PubMed:7775481). Binds single-stranded RNA (in vitro) (PubMed:7775481). May bind DNA (PubMed:7775481). Component of the nuclear export pathway (PubMed:10078529). Specific docking site for the nuclear export factor exportin-1 (PubMed:10078529). Inhibits EIF4E-dependent mRNA export (PubMed:22902403). Sumoylates PML at 'Lys-490' which is essential for the proper assembly of PML-NB (PubMed:22155184). Recruits BICD2 to the nuclear envelope and cytoplasmic stacks of nuclear pore complex known as annulate lamellae during G2 phase of cell cycle (PubMed:20386726). Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity (PubMed:20676357, PubMed:23353830). {ECO:0000269|PubMed:11792325, ECO:0000269|PubMed:12032081, ECO:0000269|PubMed:15378033, ECO:0000269|PubMed:15931224, ECO:0000269|PubMed:20386726, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22194619, ECO:0000269|PubMed:22902403, ECO:0000269|PubMed:23353830, ECO:0000269|PubMed:7775481, ECO:0000303|PubMed:10078529}. |
P51617 | IRAK1 | S601 | ochoa | Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1) | Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Is rapidly recruited by MYD88 to the receptor-signaling complex upon TLR activation. Association with MYD88 leads to IRAK1 phosphorylation by IRAK4 and subsequent autophosphorylation and kinase activation. Phosphorylates E3 ubiquitin ligases Pellino proteins (PELI1, PELI2 and PELI3) to promote pellino-mediated polyubiquitination of IRAK1. Then, the ubiquitin-binding domain of IKBKG/NEMO binds to polyubiquitinated IRAK1 bringing together the IRAK1-MAP3K7/TAK1-TRAF6 complex and the NEMO-IKKA-IKKB complex. In turn, MAP3K7/TAK1 activates IKKs (CHUK/IKKA and IKBKB/IKKB) leading to NF-kappa-B nuclear translocation and activation. Alternatively, phosphorylates TIRAP to promote its ubiquitination and subsequent degradation. Phosphorylates the interferon regulatory factor 7 (IRF7) to induce its activation and translocation to the nucleus, resulting in transcriptional activation of type I IFN genes, which drive the cell in an antiviral state. When sumoylated, translocates to the nucleus and phosphorylates STAT3. {ECO:0000269|PubMed:11397809, ECO:0000269|PubMed:12860405, ECO:0000269|PubMed:14684752, ECO:0000269|PubMed:15084582, ECO:0000269|PubMed:15465816, ECO:0000269|PubMed:15767370, ECO:0000269|PubMed:17997719, ECO:0000269|PubMed:20400509}. |
P84022 | SMAD3 | S309 | psp | Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3) | Receptor-regulated SMAD (R-SMAD) that is an intracellular signal transducer and transcriptional modulator activated by TGF-beta (transforming growth factor) and activin type 1 receptor kinases. Binds the TRE element in the promoter region of many genes that are regulated by TGF-beta and, on formation of the SMAD3/SMAD4 complex, activates transcription. Also can form a SMAD3/SMAD4/JUN/FOS complex at the AP-1/SMAD site to regulate TGF-beta-mediated transcription. Has an inhibitory effect on wound healing probably by modulating both growth and migration of primary keratinocytes and by altering the TGF-mediated chemotaxis of monocytes. This effect on wound healing appears to be hormone-sensitive. Regulator of chondrogenesis and osteogenesis and inhibits early healing of bone fractures. Positively regulates PDPK1 kinase activity by stimulating its dissociation from the 14-3-3 protein YWHAQ which acts as a negative regulator. {ECO:0000269|PubMed:10995748, ECO:0000269|PubMed:15241418, ECO:0000269|PubMed:15588252, ECO:0000269|PubMed:16156666, ECO:0000269|PubMed:16751101, ECO:0000269|PubMed:16862174, ECO:0000269|PubMed:17327236, ECO:0000269|PubMed:19218245, ECO:0000269|PubMed:19289081, ECO:0000269|PubMed:9732876, ECO:0000269|PubMed:9892009}. |
Q15149 | PLEC | S1181 | ochoa | Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) | Interlinks intermediate filaments with microtubules and microfilaments and anchors intermediate filaments to desmosomes or hemidesmosomes. Could also bind muscle proteins such as actin to membrane complexes in muscle. May be involved not only in the filaments network, but also in the regulation of their dynamics. Structural component of muscle. Isoform 9 plays a major role in the maintenance of myofiber integrity. {ECO:0000269|PubMed:12482924, ECO:0000269|PubMed:21109228}. |
Q15149 | PLEC | S2958 | ochoa | Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1) | Interlinks intermediate filaments with microtubules and microfilaments and anchors intermediate filaments to desmosomes or hemidesmosomes. Could also bind muscle proteins such as actin to membrane complexes in muscle. May be involved not only in the filaments network, but also in the regulation of their dynamics. Structural component of muscle. Isoform 9 plays a major role in the maintenance of myofiber integrity. {ECO:0000269|PubMed:12482924, ECO:0000269|PubMed:21109228}. |
Q5FWE3 | PRRT3 | S769 | ochoa | Proline-rich transmembrane protein 3 | None |
Q5TCZ1 | SH3PXD2A | S1041 | ochoa | SH3 and PX domain-containing protein 2A (Adapter protein TKS5) (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains) | Adapter protein involved in invadopodia and podosome formation, extracellular matrix degradation and invasiveness of some cancer cells (PubMed:27789576). Binds matrix metalloproteinases (ADAMs), NADPH oxidases (NOXs) and phosphoinositides. Acts as an organizer protein that allows NOX1- or NOX3-dependent reactive oxygen species (ROS) generation and ROS localization. In association with ADAM12, mediates the neurotoxic effect of amyloid-beta peptide. {ECO:0000269|PubMed:12615925, ECO:0000269|PubMed:15710328, ECO:0000269|PubMed:15710903, ECO:0000269|PubMed:19755710, ECO:0000269|PubMed:20609497, ECO:0000269|PubMed:27789576}. |
Q5VST9 | OBSCN | S6961 | ochoa | Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK) | Structural component of striated muscles which plays a role in myofibrillogenesis. Probably involved in the assembly of myosin into sarcomeric A bands in striated muscle (PubMed:11448995, PubMed:16205939). Has serine/threonine protein kinase activity and phosphorylates N-cadherin CDH2 and sodium/potassium-transporting ATPase subunit ATP1B1 (By similarity). Binds (via the PH domain) strongly to phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), and to a lesser extent to phosphatidylinositol 3-phosphate (PtdIns(3)P), phosphatidylinositol 4-phosphate (PtdIns(4)P), phosphatidylinositol 5-phosphate (PtdIns(5)P) and phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) (PubMed:28826662). {ECO:0000250|UniProtKB:A2AAJ9, ECO:0000269|PubMed:11448995, ECO:0000269|PubMed:16205939, ECO:0000269|PubMed:28826662}. |
Q6NYC8 | PPP1R18 | S468 | ochoa | Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18) | [Isoform 1]: May target protein phosphatase 1 to F-actin cytoskeleton. {ECO:0000269|PubMed:24434620}.; FUNCTION: [Isoform 4]: May target protein phosphatase 1 to F-actin cytoskeleton. {ECO:0000269|PubMed:17374523}. |
Q6ZRV2 | FAM83H | S1096 | ochoa | Protein FAM83H | May play a major role in the structural organization and calcification of developing enamel (PubMed:18252228). May play a role in keratin cytoskeleton disassembly by recruiting CSNK1A1 to keratin filaments. Thereby, it may regulate epithelial cell migration (PubMed:23902688). {ECO:0000269|PubMed:18252228, ECO:0000269|PubMed:23902688}. |
Q7Z3J3 | RGPD4 | S1232 | ochoa | RanBP2-like and GRIP domain-containing protein 4 | None |
Q8NDX1 | PSD4 | S905 | ochoa | PH and SEC7 domain-containing protein 4 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 B) (Exchange factor for ARF6 B) (Pleckstrin homology and SEC7 domain-containing protein 4) (Telomeric of interleukin-1 cluster protein) | Guanine nucleotide exchange factor for ARF6 and ARL14/ARF7. Through ARL14 activation, controls the movement of MHC class II-containing vesicles along the actin cytoskeleton in dendritic cells. Involved in membrane recycling. Interacts with several phosphatidylinositol phosphate species, including phosphatidylinositol 3,4-bisphosphate, phosphatidylinositol 3,5-bisphosphate and phosphatidylinositol 4,5-bisphosphate. {ECO:0000269|PubMed:12082148, ECO:0000269|PubMed:21458045}. |
Q8NHQ8 | RASSF8 | S385 | ochoa | Ras association domain-containing protein 8 (Carcinoma-associated protein HOJ-1) | None |
Q96JQ0 | DCHS1 | S2983 | ochoa | Protocadherin-16 (Cadherin-19) (Cadherin-25) (Fibroblast cadherin-1) (Protein dachsous homolog 1) | Calcium-dependent cell-adhesion protein. Mediates functions in neuroprogenitor cell proliferation and differentiation. In the heart, has a critical role for proper morphogenesis of the mitral valve, acting in the regulation of cell migration involved in valve formation (PubMed:26258302). {ECO:0000269|PubMed:26258302}. |
Q96PK6 | RBM14 | S560 | ochoa | RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein) | Isoform 1 may function as a nuclear receptor coactivator, enhancing transcription through other coactivators such as NCOA6 and CITED1. Isoform 2, functions as a transcriptional repressor, modulating transcriptional activities of coactivators including isoform 1, NCOA6 and CITED1 (PubMed:11443112). Regulates centriole biogenesis by suppressing the formation of aberrant centriolar protein complexes in the cytoplasm and thus preserving mitotic spindle integrity. Prevents the formation of the STIL-CPAP complex (which can induce the formation of aberrant centriolar protein complexes) by interfering with the interaction of STIL with CPAP (PubMed:25385835). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway (PubMed:28712728). Also involved in the regulation of pre-mRNA alternative splicing (PubMed:37548402). {ECO:0000269|PubMed:11443112, ECO:0000269|PubMed:25385835, ECO:0000269|PubMed:28712728, ECO:0000269|PubMed:37548402}. |
Q96S21 | RAB40C | S256 | ochoa | Ras-related protein Rab-40C (EC 3.6.5.2) (Rar-like protein) (Ras-like protein family member 8C) (SOCS box-containing protein RAR3) | RAB40C small GTPase acts as substrate-recognition component of the ECS(RAB40C) E3 ubiquitin ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:15601820, PubMed:35512830). The Rab40 subfamily belongs to the Rab family that are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different sets of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion (PubMed:29156729). As part of the ECS(RAB40C) complex, mediates ANKRD28 ubiquitination and degradation, thereby inhibiting protein phosphatase 6 (PP6) complex activity and focal adhesion assembly during cell migration (PubMed:35512830). Also negatively regulate lipid droplets accumulation in a GTP-dependent manner (PubMed:29156729). {ECO:0000269|PubMed:15601820, ECO:0000269|PubMed:29156729, ECO:0000269|PubMed:35512830}. |
Q99569 | PKP4 | S341 | ochoa | Plakophilin-4 (p0071) | Plays a role as a regulator of Rho activity during cytokinesis. May play a role in junctional plaques. {ECO:0000269|PubMed:17115030}. |
Q99666 | RGPD5 | S1231 | ochoa | RANBP2-like and GRIP domain-containing protein 5/6 (Ran-binding protein 2-like 1/2) (RanBP2-like 1/2) (RanBP2L1) (RanBP2L2) (Sperm membrane protein BS-63) | None |
Q99959 | PKP2 | S329 | ochoa | Plakophilin-2 | A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (PubMed:25208567). Regulates focal adhesion turnover resulting in changes in focal adhesion size, cell adhesion and cell spreading, potentially via transcriptional modulation of beta-integrins (PubMed:23884246). Required to maintain gingival epithelial barrier function (PubMed:34368962). Important component of the desmosome that is also required for localization of desmosome component proteins such as DSC2, DSG2 and JUP to the desmosome cell-cell junction (PubMed:22781308, PubMed:25208567). Required for the formation of desmosome cell junctions in cardiomyocytes, thereby required for the correct formation of the heart, specifically trabeculation and formation of the atria walls (By similarity). Loss of desmosome cell junctions leads to mis-localization of DSP and DSG2 resulting in disruption of cell-cell adhesion and disordered intermediate filaments (By similarity). Modulates profibrotic gene expression in cardiomyocytes via regulation of DSP expression and subsequent activation of downstream TGFB1 and MAPK14/p38 MAPK signaling (By similarity). Required for cardiac sodium current propagation and electrical synchrony in cardiac myocytes, via ANK3 stabilization and modulation of SCN5A/Nav1.5 localization to cell-cell junctions (By similarity). Required for mitochondrial function, nuclear envelope integrity and positive regulation of SIRT3 transcription via maintaining DES localization at its nuclear envelope and cell tip anchoring points, and thereby preserving regulation of the transcriptional program (PubMed:35959657). Maintenance of nuclear envelope integrity protects against DNA damage and transcriptional dysregulation of genes, especially those involved in the electron transport chain, thereby preserving mitochondrial function and protecting against superoxide radical anion generation (PubMed:35959657). Binds single-stranded DNA (ssDNA) (PubMed:20613778). May regulate the localization of GJA1 to gap junctions in intercalated disks of the heart (PubMed:18662195). Involved in the inhibition of viral infection by influenza A viruses (IAV) (PubMed:28169297). Acts as a host restriction factor for IAV viral propagation, potentially via disrupting the interaction of IAV polymerase complex proteins (PubMed:28169297). {ECO:0000250|UniProtKB:F1M7L9, ECO:0000250|UniProtKB:Q9CQ73, ECO:0000269|PubMed:18662195, ECO:0000269|PubMed:20613778, ECO:0000269|PubMed:22781308, ECO:0000269|PubMed:23884246, ECO:0000269|PubMed:25208567, ECO:0000269|PubMed:28169297, ECO:0000269|PubMed:34368962, ECO:0000269|PubMed:35959657}. |
Q9BW71 | HIRIP3 | S500 | ochoa | HIRA-interacting protein 3 | Histone chaperone that carries a H2A-H2B histone complex and facilitates its deposition onto chromatin. {ECO:0000269|PubMed:38334665, ECO:0000269|PubMed:9710638}. |
Q9C0C2 | TNKS1BP1 | S1533 | ochoa | 182 kDa tankyrase-1-binding protein | None |
Q9P244 | LRFN1 | S716 | ochoa | Leucine-rich repeat and fibronectin type III domain-containing protein 1 (Synaptic adhesion-like molecule 2) | Promotes neurite outgrowth in hippocampal neurons. Involved in the regulation and maintenance of excitatory synapses. Induces the clustering of excitatory postsynaptic proteins, including DLG4, DLGAP1, GRIA1 and GRIN1 (By similarity). {ECO:0000250}. |
Q9P2Y5 | UVRAG | S522 | ochoa|psp | UV radiation resistance-associated gene protein (p63) | Versatile protein that is involved in regulation of different cellular pathways implicated in membrane trafficking. Involved in regulation of the COPI-dependent retrograde transport from Golgi and the endoplasmic reticulum by associating with the NRZ complex; the function is dependent on its binding to phosphatidylinositol 3-phosphate (PtdIns(3)P) (PubMed:16799551, PubMed:18552835, PubMed:20643123, PubMed:24056303, PubMed:28306502). During autophagy acts as a regulatory subunit of the alternative PI3K complex II (PI3KC3-C2) that mediates formation of phosphatidylinositol 3-phosphate and is believed to be involved in maturation of autophagosomes and endocytosis. Activates lipid kinase activity of PIK3C3 (PubMed:16799551, PubMed:20643123, PubMed:24056303, PubMed:28306502). Involved in the regulation of degradative endocytic trafficking and cytokinesis, and in regulation of ATG9A transport from the Golgi to the autophagosome; the functions seems to implicate its association with PI3KC3-C2 (PubMed:16799551, PubMed:20643123, PubMed:24056303). Involved in maturation of autophagosomes and degradative endocytic trafficking independently of BECN1 but depending on its association with a class C Vps complex (possibly the HOPS complex); the association is also proposed to promote autophagosome recruitment and activation of Rab7 and endosome-endosome fusion events (PubMed:18552835, PubMed:28306502). Enhances class C Vps complex (possibly HOPS complex) association with a SNARE complex and promotes fusogenic SNARE complex formation during late endocytic membrane fusion (PubMed:24550300). In case of negative-strand RNA virus infection is required for efficient virus entry, promotes endocytic transport of virions and is implicated in a VAMP8-specific fusogenic SNARE complex assembly (PubMed:24550300). {ECO:0000269|PubMed:18552835, ECO:0000269|PubMed:20643123, ECO:0000269|PubMed:24056303, ECO:0000269|PubMed:28306502, ECO:0000305}.; FUNCTION: Involved in maintaining chromosomal stability. Promotes DNA double-strand break (DSB) repair by association with DNA-dependent protein kinase complex DNA-PK and activating it in non-homologous end joining (NHEJ) (PubMed:22542840). Required for centrosome stability and proper chromosome segregation (PubMed:22542840). {ECO:0000269|PubMed:22542840}. |
Q9UBL3 | ASH2L | S316 | ochoa | Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein) | Transcriptional regulator (PubMed:12670868). Component or associated component of some histone methyltransferase complexes which regulates transcription through recruitment of those complexes to gene promoters (PubMed:19131338). Component of the Set1/Ash2 histone methyltransferase (HMT) complex, a complex that specifically methylates 'Lys-4' of histone H3, but not if the neighboring 'Lys-9' residue is already methylated (PubMed:19556245). As part of the MLL1/MLL complex it is involved in methylation and dimethylation at 'Lys-4' of histone H3 (PubMed:19556245). May play a role in hematopoiesis (PubMed:12670868). In association with RBBP5 and WDR5, stimulates the histone methyltransferase activities of KMT2A, KMT2B, KMT2C, KMT2D, SETD1A and SETD1B (PubMed:21220120, PubMed:22266653). {ECO:0000269|PubMed:12670868, ECO:0000269|PubMed:19131338, ECO:0000269|PubMed:19556245, ECO:0000269|PubMed:21220120, ECO:0000269|PubMed:22266653}. |
Q9UPS6 | SETD1B | S1283 | ochoa | Histone-lysine N-methyltransferase SETD1B (EC 2.1.1.364) (Lysine N-methyltransferase 2G) (SET domain-containing protein 1B) (hSET1B) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) via a non-processive mechanism (PubMed:17355966, PubMed:25561738). Part of chromatin remodeling machinery, forms H3K4me1, H3K4me2 and H3K4me3 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:17355966, PubMed:25561738). Plays an essential role in regulating the transcriptional programming of multipotent hematopoietic progenitor cells and lymphoid lineage specification during hematopoiesis (By similarity). {ECO:0000250|UniProtKB:Q8CFT2, ECO:0000269|PubMed:17355966, ECO:0000269|PubMed:25561738}. |
Q9UPT8 | ZC3H4 | S1065 | ochoa | Zinc finger CCCH domain-containing protein 4 | RNA-binding protein that suppresses transcription of long non-coding RNAs (lncRNAs) (PubMed:33767452, PubMed:33913806). LncRNAs are defined as transcripts more than 200 nucleotides that are not translated into protein (PubMed:33767452, PubMed:33913806). Together with WDR82, part of a transcription termination checkpoint that promotes transcription termination of lncRNAs and their subsequent degradation by the exosome (PubMed:33767452, PubMed:33913806). The transcription termination checkpoint is activated by the inefficiently spliced first exon of lncRNAs (PubMed:33767452). {ECO:0000269|PubMed:33767452, ECO:0000269|PubMed:33913806}. |
Q9UQ35 | SRRM2 | S150 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9Y3Q8 | TSC22D4 | S233 | ochoa | TSC22 domain family protein 4 (TSC22-related-inducible leucine zipper protein 2) | Binds DNA and acts as a transcriptional repressor (PubMed:10488076). Involved in the regulation of systematic glucose homeostasis and insulin sensitivity, via transcriptional repression of downstream insulin signaling targets such as OBP2A/LCN13 (By similarity). Acts as a negative regulator of lipogenic gene expression in hepatocytes and thereby mediates the control of very low-density lipoprotein release (PubMed:23307490). May play a role in neurite elongation and survival (By similarity). {ECO:0000250|UniProtKB:Q9EQN3, ECO:0000269|PubMed:10488076, ECO:0000269|PubMed:23307490}. |
Q9Y4A5 | TRRAP | S2075 | ochoa | Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog) | Adapter protein, which is found in various multiprotein chromatin complexes with histone acetyltransferase activity (HAT), which gives a specific tag for epigenetic transcription activation. Component of the NuA4 histone acetyltransferase complex which is responsible for acetylation of nucleosomal histones H4 and H2A. Plays a central role in MYC transcription activation, and also participates in cell transformation by MYC. Required for p53/TP53-, E2F1- and E2F4-mediated transcription activation. Also involved in transcription activation mediated by the adenovirus E1A, a viral oncoprotein that deregulates transcription of key genes. Probably acts by linking transcription factors such as E1A, MYC or E2F1 to HAT complexes such as STAGA thereby allowing transcription activation. Probably not required in the steps following histone acetylation in processes of transcription activation. May be required for the mitotic checkpoint and normal cell cycle progression. Component of a SWR1-like complex that specifically mediates the removal of histone H2A.Z/H2AZ1 from the nucleosome. May play a role in the formation and maintenance of the auditory system (By similarity). {ECO:0000250|UniProtKB:A0A0R4ITC5, ECO:0000269|PubMed:11418595, ECO:0000269|PubMed:12138177, ECO:0000269|PubMed:12660246, ECO:0000269|PubMed:12743606, ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:17967892, ECO:0000269|PubMed:24463511, ECO:0000269|PubMed:9708738}. |
Q15118 | PDK1 | S25 | EPSD | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1) | Kinase that plays a key role in regulation of glucose and fatty acid metabolism and homeostasis via phosphorylation of the pyruvate dehydrogenase subunits PDHA1 and PDHA2 (PubMed:7499431, PubMed:18541534, PubMed:22195962, PubMed:26942675, PubMed:17683942). This inhibits pyruvate dehydrogenase activity, and thereby regulates metabolite flux through the tricarboxylic acid cycle, down-regulates aerobic respiration and inhibits the formation of acetyl-coenzyme A from pyruvate (PubMed:18541534, PubMed:22195962, PubMed:26942675). Plays an important role in cellular responses to hypoxia and is important for cell proliferation under hypoxia (PubMed:18541534, PubMed:22195962, PubMed:26942675). {ECO:0000269|PubMed:17683942, ECO:0000269|PubMed:18541534, ECO:0000269|PubMed:22195962, ECO:0000269|PubMed:26942675, ECO:0000269|PubMed:7499431}. |
O60566 | BUB1B | S694 | Sugiyama | Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (EC 2.7.11.1) (MAD3/BUB1-related protein kinase) (hBUBR1) (Mitotic checkpoint kinase MAD3L) (Protein SSK1) | Essential component of the mitotic checkpoint. Required for normal mitosis progression. The mitotic checkpoint delays anaphase until all chromosomes are properly attached to the mitotic spindle. One of its checkpoint functions is to inhibit the activity of the anaphase-promoting complex/cyclosome (APC/C) by blocking the binding of CDC20 to APC/C, independently of its kinase activity. The other is to monitor kinetochore activities that depend on the kinetochore motor CENPE. Required for kinetochore localization of CENPE. Negatively regulates PLK1 activity in interphase cells and suppresses centrosome amplification. Also implicated in triggering apoptosis in polyploid cells that exit aberrantly from mitotic arrest. May play a role for tumor suppression. {ECO:0000269|PubMed:10477750, ECO:0000269|PubMed:11702782, ECO:0000269|PubMed:14706340, ECO:0000269|PubMed:15020684, ECO:0000269|PubMed:19411850, ECO:0000269|PubMed:19503101}. |
P68431 | H3C1 | Y42 | EPSD | Histone H3.1 (Histone H3/a) (Histone H3/b) (Histone H3/c) (Histone H3/d) (Histone H3/f) (Histone H3/h) (Histone H3/i) (Histone H3/j) (Histone H3/k) (Histone H3/l) | Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. |
Q6P0Q8 | MAST2 | S1019 | Sugiyama | Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1) | Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation (By similarity). {ECO:0000250}. |
P84243 | H3-3A | Y42 | Sugiyama | Histone H3.3 | Variant histone H3 which replaces conventional H3 in a wide range of nucleosomes in active genes. Constitutes the predominant form of histone H3 in non-dividing cells and is incorporated into chromatin independently of DNA synthesis. Deposited at sites of nucleosomal displacement throughout transcribed genes, suggesting that it represents an epigenetic imprint of transcriptionally active chromatin. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. {ECO:0000269|PubMed:14718166, ECO:0000269|PubMed:15776021, ECO:0000269|PubMed:16258499}. |
Q16695 | H3-4 | Y42 | Sugiyama | Histone H3.1t (H3/t) (H3t) (H3/g) (Histone H3.4) | Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. |
Q71DI3 | H3C15 | Y42 | Sugiyama | Histone H3.2 (H3-clustered histone 13) (H3-clustered histone 14) (H3-clustered histone 15) (Histone H3/m) (Histone H3/o) | Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 1.291229e-07 | 6.889 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 7.320523e-06 | 5.135 |
R-HSA-2299718 | Condensation of Prophase Chromosomes | 4.040787e-05 | 4.394 |
R-HSA-3214841 | PKMTs methylate histone lysines | 2.561932e-05 | 4.591 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 4.251638e-05 | 4.371 |
R-HSA-912446 | Meiotic recombination | 5.684702e-05 | 4.245 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 6.462238e-05 | 4.190 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 7.391551e-05 | 4.131 |
R-HSA-68875 | Mitotic Prophase | 1.070764e-04 | 3.970 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 1.353515e-04 | 3.869 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 1.735642e-04 | 3.761 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 1.735642e-04 | 3.761 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 1.820519e-04 | 3.740 |
R-HSA-73728 | RNA Polymerase I Promoter Opening | 2.199404e-04 | 3.658 |
R-HSA-5334118 | DNA methylation | 2.611149e-04 | 3.583 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 2.611170e-04 | 3.583 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 3.376237e-04 | 3.472 |
R-HSA-1500620 | Meiosis | 3.215561e-04 | 3.493 |
R-HSA-73887 | Death Receptor Signaling | 3.376237e-04 | 3.472 |
R-HSA-162582 | Signal Transduction | 3.217232e-04 | 3.493 |
R-HSA-68616 | Assembly of the ORC complex at the origin of replication | 3.577270e-04 | 3.446 |
R-HSA-9843970 | Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | 4.135952e-04 | 3.383 |
R-HSA-212300 | PRC2 methylates histones and DNA | 4.747837e-04 | 3.324 |
R-HSA-427359 | SIRT1 negatively regulates rRNA expression | 5.074367e-04 | 3.295 |
R-HSA-68886 | M Phase | 4.866985e-04 | 3.313 |
R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 6.139295e-04 | 3.212 |
R-HSA-9821002 | Chromatin modifications during the maternal to zygotic transition (MZT) | 6.523529e-04 | 3.186 |
R-HSA-5625886 | Activated PKN1 stimulates transcription of AR (androgen receptor) regulated gene... | 6.523529e-04 | 3.186 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 7.336940e-04 | 3.134 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 7.336940e-04 | 3.134 |
R-HSA-9710421 | Defective pyroptosis | 7.767335e-04 | 3.110 |
R-HSA-8851680 | Butyrophilin (BTN) family interactions | 8.325973e-04 | 3.080 |
R-HSA-211000 | Gene Silencing by RNA | 8.063602e-04 | 3.093 |
R-HSA-195721 | Signaling by WNT | 8.266771e-04 | 3.083 |
R-HSA-212165 | Epigenetic regulation of gene expression | 1.218196e-03 | 2.914 |
R-HSA-73772 | RNA Polymerase I Promoter Escape | 1.237172e-03 | 2.908 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 1.463794e-03 | 2.835 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 1.463794e-03 | 2.835 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 1.463794e-03 | 2.835 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 1.352655e-03 | 2.869 |
R-HSA-209543 | p75NTR recruits signalling complexes | 1.467039e-03 | 2.834 |
R-HSA-193648 | NRAGE signals death through JNK | 1.486825e-03 | 2.828 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 1.663981e-03 | 2.779 |
R-HSA-1474165 | Reproduction | 1.704933e-03 | 2.768 |
R-HSA-3247509 | Chromatin modifying enzymes | 1.912226e-03 | 2.718 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 1.766006e-03 | 2.753 |
R-HSA-9764725 | Negative Regulation of CDH1 Gene Transcription | 1.766006e-03 | 2.753 |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | 1.917048e-03 | 2.717 |
R-HSA-193639 | p75NTR signals via NF-kB | 2.054982e-03 | 2.687 |
R-HSA-9735871 | SARS-CoV-1 targets host intracellular signalling and regulatory pathways | 2.054982e-03 | 2.687 |
R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins | 2.600892e-03 | 2.585 |
R-HSA-4839726 | Chromatin organization | 2.449476e-03 | 2.611 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 2.734637e-03 | 2.563 |
R-HSA-9764560 | Regulation of CDH1 Gene Transcription | 2.600892e-03 | 2.585 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 2.891399e-03 | 2.539 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 3.201154e-03 | 2.495 |
R-HSA-73864 | RNA Polymerase I Transcription | 3.418550e-03 | 2.466 |
R-HSA-416482 | G alpha (12/13) signalling events | 3.418550e-03 | 2.466 |
R-HSA-1640170 | Cell Cycle | 3.587076e-03 | 2.445 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 4.124267e-03 | 2.385 |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | 3.879996e-03 | 2.411 |
R-HSA-977225 | Amyloid fiber formation | 3.761268e-03 | 2.425 |
R-HSA-69278 | Cell Cycle, Mitotic | 4.142391e-03 | 2.383 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 4.451221e-03 | 2.352 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 4.701413e-03 | 2.328 |
R-HSA-9645723 | Diseases of programmed cell death | 4.775287e-03 | 2.321 |
R-HSA-3214842 | HDMs demethylate histones | 5.326498e-03 | 2.274 |
R-HSA-2559583 | Cellular Senescence | 5.139194e-03 | 2.289 |
R-HSA-68867 | Assembly of the pre-replicative complex | 5.634322e-03 | 2.249 |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | 5.194054e-03 | 2.284 |
R-HSA-1266695 | Interleukin-7 signaling | 5.326498e-03 | 2.274 |
R-HSA-3214847 | HATs acetylate histones | 6.746848e-03 | 2.171 |
R-HSA-389948 | Co-inhibition by PD-1 | 7.163492e-03 | 2.145 |
R-HSA-9842860 | Regulation of endogenous retroelements | 7.260822e-03 | 2.139 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 7.260822e-03 | 2.139 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 7.260822e-03 | 2.139 |
R-HSA-69002 | DNA Replication Pre-Initiation | 8.742849e-03 | 2.058 |
R-HSA-3315487 | SMAD2/3 MH2 Domain Mutants in Cancer | 1.037957e-02 | 1.984 |
R-HSA-3311021 | SMAD4 MH2 Domain Mutants in Cancer | 1.037957e-02 | 1.984 |
R-HSA-3304347 | Loss of Function of SMAD4 in Cancer | 1.037957e-02 | 1.984 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 9.541771e-03 | 2.020 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 1.064148e-02 | 1.973 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 1.094260e-02 | 1.961 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 9.545605e-03 | 2.020 |
R-HSA-3371556 | Cellular response to heat stress | 1.173616e-02 | 1.930 |
R-HSA-73886 | Chromosome Maintenance | 1.173616e-02 | 1.930 |
R-HSA-9670095 | Inhibition of DNA recombination at telomere | 1.181742e-02 | 1.927 |
R-HSA-3371568 | Attenuation phase | 1.181742e-02 | 1.927 |
R-HSA-8939211 | ESR-mediated signaling | 1.233444e-02 | 1.909 |
R-HSA-157118 | Signaling by NOTCH | 1.282250e-02 | 1.892 |
R-HSA-3214858 | RMTs methylate histone arginines | 1.430659e-02 | 1.844 |
R-HSA-9944997 | Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | 1.724042e-02 | 1.763 |
R-HSA-9944971 | Loss of Function of KMT2D in Kabuki Syndrome | 1.724042e-02 | 1.763 |
R-HSA-8941237 | Invadopodia formation | 1.724042e-02 | 1.763 |
R-HSA-417973 | Adenosine P1 receptors | 1.724042e-02 | 1.763 |
R-HSA-3371571 | HSF1-dependent transactivation | 1.813539e-02 | 1.741 |
R-HSA-9018519 | Estrogen-dependent gene expression | 1.635487e-02 | 1.786 |
R-HSA-74160 | Gene expression (Transcription) | 1.728021e-02 | 1.762 |
R-HSA-212436 | Generic Transcription Pathway | 1.831749e-02 | 1.737 |
R-HSA-446728 | Cell junction organization | 2.009654e-02 | 1.697 |
R-HSA-8953897 | Cellular responses to stimuli | 1.858200e-02 | 1.731 |
R-HSA-3214815 | HDACs deacetylate histones | 2.049636e-02 | 1.688 |
R-HSA-8952158 | RUNX3 regulates BCL2L11 (BIM) transcription | 2.065330e-02 | 1.685 |
R-HSA-3656532 | TGFBR1 KD Mutants in Cancer | 2.065330e-02 | 1.685 |
R-HSA-69306 | DNA Replication | 2.186029e-02 | 1.660 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 2.297851e-02 | 1.639 |
R-HSA-9610379 | HCMV Late Events | 2.320529e-02 | 1.634 |
R-HSA-3304356 | SMAD2/3 Phosphorylation Motif Mutants in Cancer | 2.405455e-02 | 1.619 |
R-HSA-165158 | Activation of AKT2 | 2.405455e-02 | 1.619 |
R-HSA-3656534 | Loss of Function of TGFBR1 in Cancer | 2.405455e-02 | 1.619 |
R-HSA-3304349 | Loss of Function of SMAD2/3 in Cancer | 2.744419e-02 | 1.562 |
R-HSA-8941855 | RUNX3 regulates CDKN1A transcription | 2.744419e-02 | 1.562 |
R-HSA-187024 | NGF-independant TRKA activation | 2.744419e-02 | 1.562 |
R-HSA-5693606 | DNA Double Strand Break Response | 2.829173e-02 | 1.548 |
R-HSA-446107 | Type I hemidesmosome assembly | 3.754389e-02 | 1.425 |
R-HSA-3304351 | Signaling by TGF-beta Receptor Complex in Cancer | 3.082227e-02 | 1.511 |
R-HSA-68877 | Mitotic Prometaphase | 3.773918e-02 | 1.423 |
R-HSA-187015 | Activation of TRKA receptors | 3.418882e-02 | 1.466 |
R-HSA-444257 | RSK activation | 3.754389e-02 | 1.425 |
R-HSA-9856530 | High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR... | 3.785538e-02 | 1.422 |
R-HSA-73857 | RNA Polymerase II Transcription | 3.233999e-02 | 1.490 |
R-HSA-1500931 | Cell-Cell communication | 2.950694e-02 | 1.530 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 2.941545e-02 | 1.531 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 2.941545e-02 | 1.531 |
R-HSA-9678108 | SARS-CoV-1 Infection | 3.019851e-02 | 1.520 |
R-HSA-9609690 | HCMV Early Events | 3.908161e-02 | 1.408 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 3.908161e-02 | 1.408 |
R-HSA-9694516 | SARS-CoV-2 Infection | 3.949867e-02 | 1.403 |
R-HSA-9634635 | Estrogen-stimulated signaling through PRKCZ | 4.088751e-02 | 1.388 |
R-HSA-264870 | Caspase-mediated cleavage of cytoskeletal proteins | 4.088751e-02 | 1.388 |
R-HSA-5687128 | MAPK6/MAPK4 signaling | 4.181957e-02 | 1.379 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 4.263049e-02 | 1.370 |
R-HSA-141424 | Amplification of signal from the kinetochores | 4.263049e-02 | 1.370 |
R-HSA-438064 | Post NMDA receptor activation events | 4.427003e-02 | 1.354 |
R-HSA-975144 | IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | 5.414828e-02 | 1.266 |
R-HSA-937039 | IRAK1 recruits IKK complex | 5.414828e-02 | 1.266 |
R-HSA-141430 | Inactivation of APC/C via direct inhibition of the APC/C complex | 7.047124e-02 | 1.152 |
R-HSA-179409 | APC-Cdc20 mediated degradation of Nek2A | 8.651745e-02 | 1.063 |
R-HSA-171306 | Packaging Of Telomere Ends | 1.085260e-01 | 0.964 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 1.177980e-01 | 0.929 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 1.208676e-01 | 0.918 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 1.208676e-01 | 0.918 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 1.269753e-01 | 0.896 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 1.269753e-01 | 0.896 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 1.300135e-01 | 0.886 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 1.360588e-01 | 0.866 |
R-HSA-9823730 | Formation of definitive endoderm | 8.333013e-02 | 1.079 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 5.728155e-02 | 1.242 |
R-HSA-2173795 | Downregulation of SMAD2/3:SMAD4 transcriptional activity | 1.239266e-01 | 0.907 |
R-HSA-141405 | Inhibition of the proteolytic activity of APC/C required for the onset of anapha... | 7.047124e-02 | 1.152 |
R-HSA-975110 | TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | 7.047124e-02 | 1.152 |
R-HSA-9754189 | Germ layer formation at gastrulation | 8.013188e-02 | 1.096 |
R-HSA-209560 | NF-kB is activated and signals survival | 5.085007e-02 | 1.294 |
R-HSA-9796292 | Formation of axial mesoderm | 5.743524e-02 | 1.241 |
R-HSA-8849932 | Synaptic adhesion-like molecules | 7.692267e-02 | 1.114 |
R-HSA-163615 | PKA activation | 7.692267e-02 | 1.114 |
R-HSA-164378 | PKA activation in glucagon signalling | 7.692267e-02 | 1.114 |
R-HSA-418885 | DCC mediated attractive signaling | 6.397553e-02 | 1.194 |
R-HSA-1181150 | Signaling by NODAL | 8.333013e-02 | 1.079 |
R-HSA-1502540 | Signaling by Activin | 6.397553e-02 | 1.194 |
R-HSA-9755779 | SARS-CoV-2 targets host intracellular signalling and regulatory pathways | 6.397553e-02 | 1.194 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 1.300135e-01 | 0.886 |
R-HSA-442720 | CREB1 phosphorylation through the activation of Adenylate Cyclase | 5.743524e-02 | 1.241 |
R-HSA-450321 | JNK (c-Jun kinases) phosphorylation and activation mediated by activated human ... | 8.651745e-02 | 1.063 |
R-HSA-9821993 | Replacement of protamines by nucleosomes in the male pronucleus | 9.915826e-02 | 1.004 |
R-HSA-389357 | CD28 dependent PI3K/Akt signaling | 1.085260e-01 | 0.964 |
R-HSA-6809371 | Formation of the cornified envelope | 8.350435e-02 | 1.078 |
R-HSA-9609646 | HCMV Infection | 6.786625e-02 | 1.168 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 8.043290e-02 | 1.095 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 1.194331e-01 | 0.923 |
R-HSA-111931 | PKA-mediated phosphorylation of CREB | 8.651745e-02 | 1.063 |
R-HSA-9008059 | Interleukin-37 signaling | 1.177980e-01 | 0.929 |
R-HSA-180746 | Nuclear import of Rev protein | 1.330413e-01 | 0.876 |
R-HSA-9617828 | FOXO-mediated transcription of cell cycle genes | 8.969389e-02 | 1.047 |
R-HSA-2173788 | Downregulation of TGF-beta receptor signaling | 9.285948e-02 | 1.032 |
R-HSA-392451 | G beta:gamma signalling through PI3Kgamma | 9.601426e-02 | 1.018 |
R-HSA-429947 | Deadenylation of mRNA | 9.915826e-02 | 1.004 |
R-HSA-446652 | Interleukin-1 family signaling | 1.182933e-01 | 0.927 |
R-HSA-2467813 | Separation of Sister Chromatids | 1.321489e-01 | 0.879 |
R-HSA-9754560 | SARS-CoV-2 modulates autophagy | 4.754056e-02 | 1.323 |
R-HSA-450302 | activated TAK1 mediates p38 MAPK activation | 8.969389e-02 | 1.047 |
R-HSA-110330 | Recognition and association of DNA glycosylase with site containing an affected ... | 1.239266e-01 | 0.907 |
R-HSA-9930044 | Nuclear RNA decay | 1.269753e-01 | 0.896 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 6.660464e-02 | 1.176 |
R-HSA-9675151 | Disorders of Developmental Biology | 7.047124e-02 | 1.152 |
R-HSA-180024 | DARPP-32 events | 1.147179e-01 | 0.940 |
R-HSA-204174 | Regulation of pyruvate dehydrogenase (PDH) complex | 1.147179e-01 | 0.940 |
R-HSA-163359 | Glucagon signaling in metabolic regulation | 1.300135e-01 | 0.886 |
R-HSA-157579 | Telomere Maintenance | 5.458228e-02 | 1.263 |
R-HSA-442742 | CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | 1.269753e-01 | 0.896 |
R-HSA-3371511 | HSF1 activation | 1.390659e-01 | 0.857 |
R-HSA-70171 | Glycolysis | 5.728155e-02 | 1.242 |
R-HSA-69620 | Cell Cycle Checkpoints | 7.268292e-02 | 1.139 |
R-HSA-9839394 | TGFBR3 expression | 1.022915e-01 | 0.990 |
R-HSA-114604 | GPVI-mediated activation cascade | 1.390659e-01 | 0.857 |
R-HSA-9013695 | NOTCH4 Intracellular Domain Regulates Transcription | 8.651745e-02 | 1.063 |
R-HSA-5674400 | Constitutive Signaling by AKT1 E17K in Cancer | 9.601426e-02 | 1.018 |
R-HSA-70326 | Glucose metabolism | 7.639518e-02 | 1.117 |
R-HSA-111933 | Calmodulin induced events | 1.390659e-01 | 0.857 |
R-HSA-5218921 | VEGFR2 mediated cell proliferation | 1.022915e-01 | 0.990 |
R-HSA-111997 | CaM pathway | 1.390659e-01 | 0.857 |
R-HSA-9860931 | Response of endothelial cells to shear stress | 6.095194e-02 | 1.215 |
R-HSA-1280218 | Adaptive Immune System | 7.576156e-02 | 1.121 |
R-HSA-6804115 | TP53 regulates transcription of additional cell cycle genes whose exact role in ... | 9.285948e-02 | 1.032 |
R-HSA-9006925 | Intracellular signaling by second messengers | 1.316093e-01 | 0.881 |
R-HSA-418038 | Nucleotide-like (purinergic) receptors | 7.692267e-02 | 1.114 |
R-HSA-397795 | G-protein beta:gamma signalling | 1.269753e-01 | 0.896 |
R-HSA-9855142 | Cellular responses to mechanical stimuli | 7.144413e-02 | 1.146 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 1.070569e-01 | 0.970 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 6.375668e-02 | 1.195 |
R-HSA-5683057 | MAPK family signaling cascades | 1.355408e-01 | 0.868 |
R-HSA-168638 | NOD1/2 Signaling Pathway | 1.330413e-01 | 0.876 |
R-HSA-110328 | Recognition and association of DNA glycosylase with site containing an affected ... | 1.330413e-01 | 0.876 |
R-HSA-388396 | GPCR downstream signalling | 5.727899e-02 | 1.242 |
R-HSA-182971 | EGFR downregulation | 1.208676e-01 | 0.918 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 5.910670e-02 | 1.228 |
R-HSA-354192 | Integrin signaling | 1.269753e-01 | 0.896 |
R-HSA-9824446 | Viral Infection Pathways | 1.020780e-01 | 0.991 |
R-HSA-2262752 | Cellular responses to stress | 6.773236e-02 | 1.169 |
R-HSA-9679504 | Translation of Replicase and Assembly of the Replication Transcription Complex | 7.692267e-02 | 1.114 |
R-HSA-6804757 | Regulation of TP53 Degradation | 1.390659e-01 | 0.857 |
R-HSA-8941326 | RUNX2 regulates bone development | 1.390659e-01 | 0.857 |
R-HSA-9694676 | Translation of Replicase and Assembly of the Replication Transcription Complex | 9.285948e-02 | 1.032 |
R-HSA-9679506 | SARS-CoV Infections | 4.964296e-02 | 1.304 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 1.239266e-01 | 0.907 |
R-HSA-8986944 | Transcriptional Regulation by MECP2 | 4.761850e-02 | 1.322 |
R-HSA-372790 | Signaling by GPCR | 8.365487e-02 | 1.078 |
R-HSA-418990 | Adherens junctions interactions | 5.017117e-02 | 1.300 |
R-HSA-421270 | Cell-cell junction organization | 6.845999e-02 | 1.165 |
R-HSA-1266738 | Developmental Biology | 1.400864e-01 | 0.854 |
R-HSA-418555 | G alpha (s) signalling events | 1.415863e-01 | 0.849 |
R-HSA-2173796 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | 1.420628e-01 | 0.848 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 1.420628e-01 | 0.848 |
R-HSA-110331 | Cleavage of the damaged purine | 1.420628e-01 | 0.848 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 1.420628e-01 | 0.848 |
R-HSA-5689880 | Ub-specific processing proteases | 1.439684e-01 | 0.842 |
R-HSA-73927 | Depurination | 1.450494e-01 | 0.838 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 1.450494e-01 | 0.838 |
R-HSA-109582 | Hemostasis | 1.473625e-01 | 0.832 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 1.480259e-01 | 0.830 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 1.480259e-01 | 0.830 |
R-HSA-6806003 | Regulation of TP53 Expression and Degradation | 1.480259e-01 | 0.830 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 1.509921e-01 | 0.821 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 1.509921e-01 | 0.821 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 1.509921e-01 | 0.821 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 1.539482e-01 | 0.813 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 1.539482e-01 | 0.813 |
R-HSA-5218920 | VEGFR2 mediated vascular permeability | 1.539482e-01 | 0.813 |
R-HSA-5675221 | Negative regulation of MAPK pathway | 1.568942e-01 | 0.804 |
R-HSA-9615017 | FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | 1.568942e-01 | 0.804 |
R-HSA-381676 | Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | 1.598301e-01 | 0.796 |
R-HSA-111996 | Ca-dependent events | 1.598301e-01 | 0.796 |
R-HSA-110329 | Cleavage of the damaged pyrimidine | 1.598301e-01 | 0.796 |
R-HSA-73928 | Depyrimidination | 1.598301e-01 | 0.796 |
R-HSA-379716 | Cytosolic tRNA aminoacylation | 1.598301e-01 | 0.796 |
R-HSA-2173789 | TGF-beta receptor signaling activates SMADs | 1.627560e-01 | 0.788 |
R-HSA-373752 | Netrin-1 signaling | 1.656718e-01 | 0.781 |
R-HSA-3928662 | EPHB-mediated forward signaling | 1.656718e-01 | 0.781 |
R-HSA-5683826 | Surfactant metabolism | 1.656718e-01 | 0.781 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 1.685777e-01 | 0.773 |
R-HSA-774815 | Nucleosome assembly | 1.685777e-01 | 0.773 |
R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere | 1.685777e-01 | 0.773 |
R-HSA-9660821 | ADORA2B mediated anti-inflammatory cytokines production | 1.685777e-01 | 0.773 |
R-HSA-432040 | Vasopressin regulates renal water homeostasis via Aquaporins | 1.685777e-01 | 0.773 |
R-HSA-1489509 | DAG and IP3 signaling | 1.685777e-01 | 0.773 |
R-HSA-76009 | Platelet Aggregation (Plug Formation) | 1.685777e-01 | 0.773 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 1.714737e-01 | 0.766 |
R-HSA-9861718 | Regulation of pyruvate metabolism | 1.714737e-01 | 0.766 |
R-HSA-9839373 | Signaling by TGFBR3 | 1.714737e-01 | 0.766 |
R-HSA-75153 | Apoptotic execution phase | 1.714737e-01 | 0.766 |
R-HSA-445989 | TAK1-dependent IKK and NF-kappa-B activation | 1.743597e-01 | 0.759 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 1.772359e-01 | 0.751 |
R-HSA-9634597 | GPER1 signaling | 1.772359e-01 | 0.751 |
R-HSA-389356 | Co-stimulation by CD28 | 1.772359e-01 | 0.751 |
R-HSA-70263 | Gluconeogenesis | 1.772359e-01 | 0.751 |
R-HSA-109704 | PI3K Cascade | 1.829587e-01 | 0.738 |
R-HSA-6805567 | Keratinization | 1.856118e-01 | 0.731 |
R-HSA-449147 | Signaling by Interleukins | 1.867271e-01 | 0.729 |
R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 1.886425e-01 | 0.724 |
R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of th... | 1.914698e-01 | 0.718 |
R-HSA-1221632 | Meiotic synapsis | 1.914698e-01 | 0.718 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 1.931420e-01 | 0.714 |
R-HSA-73929 | Base-Excision Repair, AP Site Formation | 1.942874e-01 | 0.712 |
R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | 1.970953e-01 | 0.705 |
R-HSA-68882 | Mitotic Anaphase | 1.981853e-01 | 0.703 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 1.994489e-01 | 0.700 |
R-HSA-2173793 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | 1.998937e-01 | 0.699 |
R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 1.998937e-01 | 0.699 |
R-HSA-177929 | Signaling by EGFR | 1.998937e-01 | 0.699 |
R-HSA-112399 | IRS-mediated signalling | 2.026825e-01 | 0.693 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 2.026825e-01 | 0.693 |
R-HSA-6791312 | TP53 Regulates Transcription of Cell Cycle Genes | 2.026825e-01 | 0.693 |
R-HSA-9772572 | Early SARS-CoV-2 Infection Events | 2.054617e-01 | 0.687 |
R-HSA-194441 | Metabolism of non-coding RNA | 2.082314e-01 | 0.681 |
R-HSA-191859 | snRNP Assembly | 2.082314e-01 | 0.681 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 2.082314e-01 | 0.681 |
R-HSA-2022090 | Assembly of collagen fibrils and other multimeric structures | 2.082314e-01 | 0.681 |
R-HSA-8873719 | RAB geranylgeranylation | 2.109917e-01 | 0.676 |
R-HSA-5362517 | Signaling by Retinoic Acid | 2.109917e-01 | 0.676 |
R-HSA-379724 | tRNA Aminoacylation | 2.109917e-01 | 0.676 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 2.137424e-01 | 0.670 |
R-HSA-2428928 | IRS-related events triggered by IGF1R | 2.137424e-01 | 0.670 |
R-HSA-445717 | Aquaporin-mediated transport | 2.137424e-01 | 0.670 |
R-HSA-450294 | MAP kinase activation | 2.137424e-01 | 0.670 |
R-HSA-112043 | PLC beta mediated events | 2.137424e-01 | 0.670 |
R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | 2.164838e-01 | 0.665 |
R-HSA-6784531 | tRNA processing in the nucleus | 2.164838e-01 | 0.665 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 2.164838e-01 | 0.665 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 2.192158e-01 | 0.659 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 2.192158e-01 | 0.659 |
R-HSA-2428924 | IGF1R signaling cascade | 2.219384e-01 | 0.654 |
R-HSA-74751 | Insulin receptor signalling cascade | 2.219384e-01 | 0.654 |
R-HSA-168643 | Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signali... | 2.219384e-01 | 0.654 |
R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 2.246517e-01 | 0.648 |
R-HSA-8854518 | AURKA Activation by TPX2 | 2.273557e-01 | 0.643 |
R-HSA-112040 | G-protein mediated events | 2.300504e-01 | 0.638 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 2.327359e-01 | 0.633 |
R-HSA-448424 | Interleukin-17 signaling | 2.380794e-01 | 0.623 |
R-HSA-453276 | Regulation of mitotic cell cycle | 2.407374e-01 | 0.618 |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | 2.407374e-01 | 0.618 |
R-HSA-5663205 | Infectious disease | 2.412659e-01 | 0.618 |
R-HSA-112316 | Neuronal System | 2.416696e-01 | 0.617 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 2.460261e-01 | 0.609 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 2.460261e-01 | 0.609 |
R-HSA-5688426 | Deubiquitination | 2.480377e-01 | 0.605 |
R-HSA-69473 | G2/M DNA damage checkpoint | 2.486568e-01 | 0.604 |
R-HSA-9013694 | Signaling by NOTCH4 | 2.486568e-01 | 0.604 |
R-HSA-380287 | Centrosome maturation | 2.512786e-01 | 0.600 |
R-HSA-1169408 | ISG15 antiviral mechanism | 2.512786e-01 | 0.600 |
R-HSA-416476 | G alpha (q) signalling events | 2.596445e-01 | 0.586 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 2.668215e-01 | 0.574 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 2.693809e-01 | 0.570 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 2.744736e-01 | 0.561 |
R-HSA-6794362 | Protein-protein interactions at synapses | 2.770068e-01 | 0.558 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 2.790086e-01 | 0.554 |
R-HSA-70268 | Pyruvate metabolism | 2.845546e-01 | 0.546 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 2.859181e-01 | 0.544 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 2.870532e-01 | 0.542 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 2.920249e-01 | 0.535 |
R-HSA-202424 | Downstream TCR signaling | 2.920249e-01 | 0.535 |
R-HSA-73884 | Base Excision Repair | 2.920249e-01 | 0.535 |
R-HSA-74752 | Signaling by Insulin receptor | 2.994186e-01 | 0.524 |
R-HSA-2682334 | EPH-Ephrin signaling | 2.994186e-01 | 0.524 |
R-HSA-1257604 | PIP3 activates AKT signaling | 2.996398e-01 | 0.523 |
R-HSA-9837999 | Mitochondrial protein degradation | 3.043055e-01 | 0.517 |
R-HSA-1474290 | Collagen formation | 3.043055e-01 | 0.517 |
R-HSA-2730905 | Role of LAT2/NTAL/LAB on calcium mobilization | 3.115732e-01 | 0.506 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 3.115732e-01 | 0.506 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 3.139792e-01 | 0.503 |
R-HSA-8878159 | Transcriptional regulation by RUNX3 | 3.139792e-01 | 0.503 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 3.163769e-01 | 0.500 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 3.163769e-01 | 0.500 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 3.163769e-01 | 0.500 |
R-HSA-422356 | Regulation of insulin secretion | 3.163769e-01 | 0.500 |
R-HSA-9614085 | FOXO-mediated transcription | 3.187664e-01 | 0.497 |
R-HSA-5610787 | Hedgehog 'off' state | 3.211476e-01 | 0.493 |
R-HSA-9020702 | Interleukin-1 signaling | 3.235207e-01 | 0.490 |
R-HSA-9009391 | Extra-nuclear estrogen signaling | 3.235207e-01 | 0.490 |
R-HSA-111885 | Opioid Signalling | 3.305912e-01 | 0.481 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 3.322861e-01 | 0.478 |
R-HSA-392499 | Metabolism of proteins | 3.342528e-01 | 0.476 |
R-HSA-168164 | Toll Like Receptor 3 (TLR3) Cascade | 3.352645e-01 | 0.475 |
R-HSA-112315 | Transmission across Chemical Synapses | 3.355197e-01 | 0.474 |
R-HSA-9725370 | Signaling by ALK fusions and activated point mutants | 3.399057e-01 | 0.469 |
R-HSA-9700206 | Signaling by ALK in cancer | 3.399057e-01 | 0.469 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 3.422144e-01 | 0.466 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 3.445151e-01 | 0.463 |
R-HSA-1474244 | Extracellular matrix organization | 3.456883e-01 | 0.461 |
R-HSA-202403 | TCR signaling | 3.468080e-01 | 0.460 |
R-HSA-937061 | TRIF (TICAM1)-mediated TLR4 signaling | 3.468080e-01 | 0.460 |
R-HSA-166166 | MyD88-independent TLR4 cascade | 3.468080e-01 | 0.460 |
R-HSA-8953854 | Metabolism of RNA | 3.473789e-01 | 0.459 |
R-HSA-1483249 | Inositol phosphate metabolism | 3.513700e-01 | 0.454 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 3.536393e-01 | 0.451 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 3.559008e-01 | 0.449 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 3.604005e-01 | 0.443 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 3.626387e-01 | 0.441 |
R-HSA-2219528 | PI3K/AKT Signaling in Cancer | 3.693074e-01 | 0.433 |
R-HSA-5693538 | Homology Directed Repair | 3.693074e-01 | 0.433 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 3.715150e-01 | 0.430 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 3.715150e-01 | 0.430 |
R-HSA-8878166 | Transcriptional regulation by RUNX2 | 3.715150e-01 | 0.430 |
R-HSA-168256 | Immune System | 3.771375e-01 | 0.424 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 3.780925e-01 | 0.422 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 3.780925e-01 | 0.422 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 3.796552e-01 | 0.421 |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | 3.802699e-01 | 0.420 |
R-HSA-73894 | DNA Repair | 3.821197e-01 | 0.418 |
R-HSA-162909 | Host Interactions of HIV factors | 3.824398e-01 | 0.417 |
R-HSA-194138 | Signaling by VEGF | 3.867573e-01 | 0.413 |
R-HSA-9664323 | FCGR3A-mediated IL10 synthesis | 3.889050e-01 | 0.410 |
R-HSA-69481 | G2/M Checkpoints | 3.910452e-01 | 0.408 |
R-HSA-187037 | Signaling by NTRK1 (TRKA) | 3.931781e-01 | 0.405 |
R-HSA-199418 | Negative regulation of the PI3K/AKT network | 3.974218e-01 | 0.401 |
R-HSA-163685 | Integration of energy metabolism | 4.141073e-01 | 0.383 |
R-HSA-5358351 | Signaling by Hedgehog | 4.182072e-01 | 0.379 |
R-HSA-1632852 | Macroautophagy | 4.243044e-01 | 0.372 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 4.283342e-01 | 0.368 |
R-HSA-2871837 | FCERI mediated NF-kB activation | 4.323364e-01 | 0.364 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 4.402583e-01 | 0.356 |
R-HSA-166520 | Signaling by NTRKs | 4.402583e-01 | 0.356 |
R-HSA-9758941 | Gastrulation | 4.422217e-01 | 0.354 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 4.519380e-01 | 0.345 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 4.538612e-01 | 0.343 |
R-HSA-9612973 | Autophagy | 4.557778e-01 | 0.341 |
R-HSA-162587 | HIV Life Cycle | 4.576877e-01 | 0.339 |
R-HSA-9006936 | Signaling by TGFB family members | 4.633782e-01 | 0.334 |
R-HSA-5633007 | Regulation of TP53 Activity | 4.633782e-01 | 0.334 |
R-HSA-109581 | Apoptosis | 4.671393e-01 | 0.331 |
R-HSA-5619102 | SLC transporter disorders | 4.764290e-01 | 0.322 |
R-HSA-72306 | tRNA processing | 4.837460e-01 | 0.315 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 4.855595e-01 | 0.314 |
R-HSA-9662851 | Anti-inflammatory response favouring Leishmania parasite infection | 4.891678e-01 | 0.311 |
R-HSA-9664433 | Leishmania parasite growth and survival | 4.891678e-01 | 0.311 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 4.958682e-01 | 0.305 |
R-HSA-168255 | Influenza Infection | 4.998442e-01 | 0.301 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 5.069776e-01 | 0.295 |
R-HSA-69275 | G2/M Transition | 5.120232e-01 | 0.291 |
R-HSA-453274 | Mitotic G2-G2/M phases | 5.154491e-01 | 0.288 |
R-HSA-5617833 | Cilium Assembly | 5.188513e-01 | 0.285 |
R-HSA-168898 | Toll-like Receptor Cascades | 5.205437e-01 | 0.284 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 5.255856e-01 | 0.279 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 5.404011e-01 | 0.267 |
R-HSA-72172 | mRNA Splicing | 5.436312e-01 | 0.265 |
R-HSA-1643685 | Disease | 5.441800e-01 | 0.264 |
R-HSA-5357801 | Programmed Cell Death | 5.452379e-01 | 0.263 |
R-HSA-162906 | HIV Infection | 5.792121e-01 | 0.237 |
R-HSA-422475 | Axon guidance | 5.901176e-01 | 0.229 |
R-HSA-5619115 | Disorders of transmembrane transporters | 6.079268e-01 | 0.216 |
R-HSA-9675108 | Nervous system development | 6.250029e-01 | 0.204 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 6.436589e-01 | 0.191 |
R-HSA-9658195 | Leishmania infection | 6.523880e-01 | 0.185 |
R-HSA-9824443 | Parasitic Infection Pathways | 6.523880e-01 | 0.185 |
R-HSA-5673001 | RAF/MAP kinase cascade | 6.621071e-01 | 0.179 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 6.703920e-01 | 0.174 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 6.973110e-01 | 0.157 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 7.190853e-01 | 0.143 |
R-HSA-913531 | Interferon Signaling | 7.589812e-01 | 0.120 |
R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | 7.682583e-01 | 0.114 |
R-HSA-418594 | G alpha (i) signalling events | 7.787708e-01 | 0.109 |
R-HSA-72766 | Translation | 7.955042e-01 | 0.099 |
R-HSA-6798695 | Neutrophil degranulation | 8.150131e-01 | 0.089 |
R-HSA-597592 | Post-translational protein modification | 8.489841e-01 | 0.071 |
R-HSA-168249 | Innate Immune System | 8.588375e-01 | 0.066 |
R-HSA-500792 | GPCR ligand binding | 8.849706e-01 | 0.053 |
R-HSA-382551 | Transport of small molecules | 9.726133e-01 | 0.012 |
R-HSA-1430728 | Metabolism | 9.996824e-01 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
AURC |
0.687 | 0.147 | -2 | 0.595 |
WNK1 |
0.684 | 0.161 | -2 | 0.785 |
CDC7 |
0.678 | 0.087 | 1 | 0.684 |
SKMLCK |
0.677 | 0.166 | -2 | 0.731 |
PRKD2 |
0.677 | 0.061 | -3 | 0.532 |
CLK3 |
0.676 | 0.095 | 1 | 0.584 |
HIPK4 |
0.676 | 0.081 | 1 | 0.607 |
MOS |
0.676 | 0.147 | 1 | 0.731 |
PRKD1 |
0.675 | 0.110 | -3 | 0.595 |
MNK2 |
0.675 | 0.122 | -2 | 0.706 |
PIM3 |
0.675 | 0.057 | -3 | 0.551 |
COT |
0.674 | 0.051 | 2 | 0.704 |
SRPK1 |
0.673 | 0.055 | -3 | 0.476 |
MST4 |
0.673 | 0.069 | 2 | 0.721 |
CHAK2 |
0.672 | 0.094 | -1 | 0.694 |
MARK4 |
0.672 | 0.112 | 4 | 0.723 |
NEK6 |
0.671 | 0.087 | -2 | 0.614 |
NLK |
0.671 | 0.044 | 1 | 0.587 |
CDK18 |
0.671 | 0.085 | 1 | 0.449 |
RSK2 |
0.671 | 0.036 | -3 | 0.499 |
RIPK3 |
0.671 | 0.068 | 3 | 0.644 |
CDKL5 |
0.670 | 0.029 | -3 | 0.506 |
NUAK2 |
0.670 | 0.047 | -3 | 0.563 |
RSK3 |
0.669 | 0.048 | -3 | 0.485 |
AMPKA1 |
0.669 | 0.080 | -3 | 0.578 |
ERK5 |
0.669 | 0.044 | 1 | 0.565 |
MTOR |
0.669 | -0.007 | 1 | 0.540 |
TSSK1 |
0.668 | 0.103 | -3 | 0.602 |
PIM1 |
0.668 | 0.037 | -3 | 0.493 |
NDR1 |
0.668 | 0.038 | -3 | 0.556 |
ATR |
0.668 | 0.031 | 1 | 0.643 |
PRPK |
0.667 | 0.039 | -1 | 0.672 |
NDR2 |
0.667 | 0.044 | -3 | 0.590 |
AURB |
0.667 | 0.092 | -2 | 0.596 |
RAF1 |
0.666 | -0.026 | 1 | 0.569 |
TSSK2 |
0.666 | 0.095 | -5 | 0.729 |
PAK6 |
0.665 | 0.073 | -2 | 0.677 |
MNK1 |
0.665 | 0.081 | -2 | 0.676 |
PAK1 |
0.665 | 0.076 | -2 | 0.704 |
CDK7 |
0.665 | 0.048 | 1 | 0.487 |
CAMK1B |
0.665 | 0.007 | -3 | 0.563 |
P90RSK |
0.665 | 0.025 | -3 | 0.502 |
PKACB |
0.665 | 0.077 | -2 | 0.607 |
PAK3 |
0.665 | 0.071 | -2 | 0.705 |
CAMLCK |
0.665 | 0.069 | -2 | 0.701 |
PKN2 |
0.665 | 0.036 | -3 | 0.547 |
AMPKA2 |
0.664 | 0.053 | -3 | 0.549 |
PKACG |
0.664 | 0.039 | -2 | 0.640 |
SMG1 |
0.664 | 0.081 | 1 | 0.625 |
IRE1 |
0.664 | 0.060 | 1 | 0.601 |
MAPKAPK3 |
0.664 | 0.015 | -3 | 0.519 |
PDHK4 |
0.664 | -0.088 | 1 | 0.609 |
CDKL1 |
0.663 | 0.002 | -3 | 0.506 |
KIS |
0.663 | 0.013 | 1 | 0.487 |
DAPK2 |
0.663 | 0.075 | -3 | 0.579 |
DYRK2 |
0.663 | 0.047 | 1 | 0.530 |
PRKD3 |
0.662 | 0.029 | -3 | 0.498 |
NIK |
0.662 | 0.042 | -3 | 0.584 |
MLK2 |
0.662 | 0.070 | 2 | 0.682 |
ULK2 |
0.662 | -0.013 | 2 | 0.631 |
PKCZ |
0.662 | 0.085 | 2 | 0.654 |
PKCD |
0.661 | 0.053 | 2 | 0.659 |
PKG2 |
0.661 | 0.071 | -2 | 0.602 |
QIK |
0.661 | 0.031 | -3 | 0.560 |
PKCB |
0.661 | 0.072 | 2 | 0.633 |
ICK |
0.661 | 0.026 | -3 | 0.565 |
IKKB |
0.661 | -0.072 | -2 | 0.566 |
PKCA |
0.660 | 0.069 | 2 | 0.622 |
CLK2 |
0.660 | 0.091 | -3 | 0.464 |
RIPK1 |
0.660 | 0.022 | 1 | 0.588 |
NEK2 |
0.659 | 0.066 | 2 | 0.681 |
CLK4 |
0.659 | 0.051 | -3 | 0.483 |
PDHK1 |
0.659 | -0.064 | 1 | 0.572 |
WNK3 |
0.659 | -0.021 | 1 | 0.572 |
NIM1 |
0.659 | 0.027 | 3 | 0.619 |
NEK7 |
0.659 | -0.026 | -3 | 0.628 |
QSK |
0.659 | 0.051 | 4 | 0.698 |
MYLK4 |
0.658 | 0.049 | -2 | 0.664 |
HIPK1 |
0.658 | 0.053 | 1 | 0.542 |
GCN2 |
0.658 | -0.098 | 2 | 0.640 |
HIPK2 |
0.658 | 0.045 | 1 | 0.474 |
CLK1 |
0.658 | 0.049 | -3 | 0.480 |
PRKX |
0.658 | 0.059 | -3 | 0.440 |
MELK |
0.658 | 0.020 | -3 | 0.530 |
NEK9 |
0.657 | 0.010 | 2 | 0.686 |
PKN3 |
0.657 | -0.009 | -3 | 0.538 |
SSTK |
0.657 | 0.103 | 4 | 0.701 |
BMPR2 |
0.657 | -0.055 | -2 | 0.624 |
BUB1 |
0.657 | 0.196 | -5 | 0.656 |
MLK1 |
0.657 | -0.034 | 2 | 0.676 |
DSTYK |
0.656 | -0.053 | 2 | 0.728 |
TBK1 |
0.656 | -0.062 | 1 | 0.466 |
CDK13 |
0.656 | 0.027 | 1 | 0.471 |
WNK4 |
0.656 | 0.114 | -2 | 0.801 |
CDK19 |
0.656 | 0.018 | 1 | 0.426 |
P70S6KB |
0.656 | -0.006 | -3 | 0.498 |
PIM2 |
0.656 | 0.029 | -3 | 0.464 |
MLK3 |
0.656 | 0.021 | 2 | 0.629 |
PKCG |
0.655 | 0.049 | 2 | 0.618 |
CDK14 |
0.655 | 0.050 | 1 | 0.474 |
AKT2 |
0.655 | 0.025 | -3 | 0.424 |
HIPK3 |
0.655 | 0.040 | 1 | 0.525 |
SGK3 |
0.655 | 0.045 | -3 | 0.489 |
CAMK2D |
0.654 | -0.012 | -3 | 0.565 |
CDK5 |
0.654 | 0.044 | 1 | 0.508 |
P38A |
0.654 | 0.043 | 1 | 0.494 |
PKCI |
0.654 | 0.064 | 2 | 0.631 |
MARK3 |
0.654 | 0.058 | 4 | 0.671 |
CDK8 |
0.654 | -0.001 | 1 | 0.456 |
HUNK |
0.654 | 0.015 | 2 | 0.624 |
MAPKAPK2 |
0.654 | -0.004 | -3 | 0.471 |
PKR |
0.653 | 0.088 | 1 | 0.625 |
MPSK1 |
0.653 | 0.126 | 1 | 0.635 |
MASTL |
0.653 | -0.045 | -2 | 0.655 |
IKKE |
0.652 | -0.076 | 1 | 0.458 |
ERK1 |
0.652 | 0.030 | 1 | 0.431 |
CDK17 |
0.652 | 0.032 | 1 | 0.399 |
CDK9 |
0.652 | 0.019 | 1 | 0.469 |
CDK12 |
0.652 | 0.031 | 1 | 0.442 |
MSK2 |
0.652 | 0.001 | -3 | 0.470 |
CAMK2G |
0.651 | -0.079 | 2 | 0.617 |
GRK5 |
0.651 | -0.100 | -3 | 0.552 |
PAK2 |
0.651 | 0.020 | -2 | 0.696 |
P38B |
0.651 | 0.039 | 1 | 0.440 |
CDK10 |
0.651 | 0.033 | 1 | 0.466 |
CDK3 |
0.651 | 0.058 | 1 | 0.421 |
CAMK4 |
0.651 | -0.043 | -3 | 0.534 |
CDK1 |
0.651 | 0.028 | 1 | 0.452 |
DCAMKL1 |
0.650 | 0.049 | -3 | 0.528 |
PHKG1 |
0.650 | -0.020 | -3 | 0.547 |
NUAK1 |
0.650 | -0.016 | -3 | 0.511 |
CHAK1 |
0.650 | 0.014 | 2 | 0.653 |
DYRK3 |
0.650 | 0.040 | 1 | 0.553 |
BCKDK |
0.650 | -0.081 | -1 | 0.643 |
MSK1 |
0.650 | 0.028 | -3 | 0.462 |
JNK2 |
0.649 | 0.040 | 1 | 0.423 |
MARK2 |
0.649 | 0.051 | 4 | 0.664 |
PKCH |
0.649 | 0.022 | 2 | 0.604 |
SIK |
0.649 | -0.009 | -3 | 0.482 |
SRPK2 |
0.649 | -0.013 | -3 | 0.393 |
PKACA |
0.649 | 0.045 | -2 | 0.571 |
LATS2 |
0.649 | -0.006 | -5 | 0.596 |
ANKRD3 |
0.649 | -0.024 | 1 | 0.591 |
BRSK2 |
0.648 | 0.012 | -3 | 0.541 |
MAK |
0.648 | 0.078 | -2 | 0.633 |
ULK1 |
0.648 | -0.083 | -3 | 0.586 |
DYRK4 |
0.648 | 0.052 | 1 | 0.464 |
CDK16 |
0.648 | 0.044 | 1 | 0.429 |
RSK4 |
0.648 | 0.010 | -3 | 0.486 |
IRAK4 |
0.648 | 0.067 | 1 | 0.586 |
CHK1 |
0.648 | 0.027 | -3 | 0.553 |
IRE2 |
0.646 | -0.002 | 2 | 0.594 |
MEK1 |
0.646 | -0.003 | 2 | 0.688 |
P38D |
0.646 | 0.039 | 1 | 0.426 |
DYRK1A |
0.645 | 0.006 | 1 | 0.531 |
VRK2 |
0.645 | 0.080 | 1 | 0.633 |
PKCT |
0.645 | 0.037 | 2 | 0.611 |
MST3 |
0.645 | 0.057 | 2 | 0.712 |
DNAPK |
0.645 | 0.030 | 1 | 0.522 |
BRSK1 |
0.645 | -0.001 | -3 | 0.515 |
PAK5 |
0.645 | 0.036 | -2 | 0.639 |
TGFBR2 |
0.644 | -0.083 | -2 | 0.477 |
PKCE |
0.644 | 0.045 | 2 | 0.607 |
MOK |
0.644 | 0.049 | 1 | 0.592 |
DYRK1B |
0.644 | 0.020 | 1 | 0.496 |
P38G |
0.644 | 0.025 | 1 | 0.385 |
AKT1 |
0.644 | 0.014 | -3 | 0.447 |
CAMK1G |
0.644 | -0.018 | -3 | 0.467 |
JNK3 |
0.643 | 0.018 | 1 | 0.467 |
NEK5 |
0.643 | 0.093 | 1 | 0.597 |
LKB1 |
0.643 | 0.090 | -3 | 0.607 |
FAM20C |
0.642 | -0.002 | 2 | 0.459 |
ATM |
0.642 | -0.013 | 1 | 0.606 |
IKKA |
0.642 | -0.067 | -2 | 0.530 |
SRPK3 |
0.642 | -0.035 | -3 | 0.429 |
GRK1 |
0.642 | -0.034 | -2 | 0.537 |
AURA |
0.642 | 0.040 | -2 | 0.558 |
GSK3B |
0.641 | 0.045 | 4 | 0.453 |
ERK7 |
0.641 | 0.031 | 2 | 0.483 |
ERK2 |
0.641 | -0.010 | 1 | 0.478 |
YSK4 |
0.641 | -0.048 | 1 | 0.508 |
LATS1 |
0.641 | 0.030 | -3 | 0.611 |
GSK3A |
0.640 | 0.056 | 4 | 0.457 |
PRP4 |
0.640 | 0.002 | -3 | 0.518 |
PAK4 |
0.640 | 0.043 | -2 | 0.626 |
TLK2 |
0.640 | -0.010 | 1 | 0.570 |
AKT3 |
0.640 | 0.023 | -3 | 0.386 |
CDK2 |
0.640 | -0.004 | 1 | 0.511 |
SNRK |
0.640 | -0.064 | 2 | 0.516 |
CAMK2A |
0.639 | -0.024 | 2 | 0.632 |
DAPK3 |
0.639 | 0.063 | -3 | 0.518 |
MARK1 |
0.639 | -0.007 | 4 | 0.675 |
PINK1 |
0.638 | -0.073 | 1 | 0.642 |
PHKG2 |
0.638 | -0.041 | -3 | 0.518 |
BMPR1B |
0.638 | -0.013 | 1 | 0.556 |
TTBK2 |
0.638 | -0.129 | 2 | 0.544 |
DLK |
0.638 | -0.159 | 1 | 0.545 |
DRAK1 |
0.638 | -0.023 | 1 | 0.526 |
GRK6 |
0.637 | -0.109 | 1 | 0.580 |
PBK |
0.637 | 0.099 | 1 | 0.630 |
MLK4 |
0.637 | -0.056 | 2 | 0.603 |
CDK6 |
0.636 | 0.019 | 1 | 0.461 |
ROCK2 |
0.636 | 0.068 | -3 | 0.513 |
MEK5 |
0.636 | -0.064 | 2 | 0.681 |
CAMK1D |
0.635 | -0.015 | -3 | 0.432 |
PERK |
0.635 | -0.063 | -2 | 0.542 |
MAPKAPK5 |
0.635 | -0.088 | -3 | 0.422 |
CAMK2B |
0.635 | -0.043 | 2 | 0.593 |
MRCKB |
0.635 | 0.034 | -3 | 0.456 |
PKN1 |
0.635 | -0.015 | -3 | 0.451 |
CK1E |
0.635 | -0.051 | -3 | 0.372 |
SMMLCK |
0.634 | -0.006 | -3 | 0.521 |
P70S6K |
0.634 | -0.046 | -3 | 0.419 |
GRK7 |
0.633 | -0.051 | 1 | 0.555 |
NEK4 |
0.633 | 0.034 | 1 | 0.533 |
MEKK1 |
0.633 | -0.026 | 1 | 0.540 |
CDK4 |
0.633 | 0.012 | 1 | 0.442 |
CAMKK1 |
0.633 | 0.007 | -2 | 0.594 |
TAO3 |
0.633 | -0.004 | 1 | 0.535 |
DCAMKL2 |
0.632 | -0.018 | -3 | 0.547 |
MEKK2 |
0.632 | -0.039 | 2 | 0.658 |
LOK |
0.632 | 0.020 | -2 | 0.644 |
HRI |
0.632 | -0.094 | -2 | 0.577 |
TGFBR1 |
0.632 | -0.045 | -2 | 0.485 |
PLK4 |
0.632 | -0.008 | 2 | 0.437 |
SGK1 |
0.632 | 0.007 | -3 | 0.353 |
NEK1 |
0.631 | 0.081 | 1 | 0.563 |
ALK4 |
0.631 | -0.085 | -2 | 0.526 |
DAPK1 |
0.631 | 0.033 | -3 | 0.498 |
CAMKK2 |
0.631 | 0.022 | -2 | 0.609 |
MEKK6 |
0.630 | 0.027 | 1 | 0.516 |
CK1G1 |
0.630 | -0.063 | -3 | 0.354 |
GAK |
0.629 | 0.045 | 1 | 0.668 |
TNIK |
0.628 | 0.050 | 3 | 0.727 |
PDK1 |
0.628 | -0.009 | 1 | 0.548 |
HPK1 |
0.628 | 0.010 | 1 | 0.491 |
CK1D |
0.628 | -0.056 | -3 | 0.339 |
GRK4 |
0.628 | -0.168 | -2 | 0.528 |
HGK |
0.627 | 0.010 | 3 | 0.715 |
HASPIN |
0.627 | 0.105 | -1 | 0.731 |
CAMK1A |
0.627 | -0.013 | -3 | 0.405 |
NEK3 |
0.627 | 0.044 | 1 | 0.502 |
PASK |
0.627 | -0.010 | -3 | 0.594 |
CHK2 |
0.627 | -0.026 | -3 | 0.384 |
ZAK |
0.627 | -0.084 | 1 | 0.478 |
TAO2 |
0.627 | -0.025 | 2 | 0.697 |
STK33 |
0.626 | -0.014 | 2 | 0.476 |
LRRK2 |
0.626 | 0.017 | 2 | 0.688 |
MRCKA |
0.625 | 0.002 | -3 | 0.469 |
ACVR2B |
0.625 | -0.079 | -2 | 0.470 |
MEKK3 |
0.625 | -0.130 | 1 | 0.527 |
CK1A2 |
0.625 | -0.060 | -3 | 0.330 |
DMPK1 |
0.625 | 0.051 | -3 | 0.481 |
SBK |
0.625 | -0.021 | -3 | 0.330 |
PLK1 |
0.625 | -0.122 | -2 | 0.508 |
PKG1 |
0.624 | 0.008 | -2 | 0.560 |
TLK1 |
0.624 | -0.095 | -2 | 0.505 |
NEK11 |
0.624 | -0.068 | 1 | 0.498 |
NEK8 |
0.624 | -0.069 | 2 | 0.669 |
KHS2 |
0.624 | 0.035 | 1 | 0.498 |
BRAF |
0.624 | -0.109 | -4 | 0.399 |
ACVR2A |
0.623 | -0.102 | -2 | 0.464 |
ALK2 |
0.623 | -0.078 | -2 | 0.486 |
KHS1 |
0.623 | 0.033 | 1 | 0.494 |
LIMK2_TYR |
0.622 | 0.163 | -3 | 0.623 |
ROCK1 |
0.622 | 0.037 | -3 | 0.463 |
MAP3K15 |
0.622 | 0.001 | 1 | 0.483 |
MEK2 |
0.622 | -0.007 | 2 | 0.653 |
MINK |
0.622 | -0.006 | 1 | 0.496 |
IRAK1 |
0.622 | -0.128 | -1 | 0.659 |
YSK1 |
0.622 | 0.013 | 2 | 0.681 |
PDHK3_TYR |
0.621 | 0.216 | 4 | 0.711 |
CK2A2 |
0.621 | 0.056 | 1 | 0.686 |
JNK1 |
0.620 | -0.007 | 1 | 0.442 |
GCK |
0.620 | -0.020 | 1 | 0.504 |
SLK |
0.620 | -0.029 | -2 | 0.582 |
CRIK |
0.619 | 0.011 | -3 | 0.454 |
MYO3B |
0.619 | 0.063 | 2 | 0.695 |
VRK1 |
0.619 | 0.067 | 2 | 0.640 |
PLK3 |
0.618 | -0.125 | 2 | 0.597 |
CK2A1 |
0.617 | 0.062 | 1 | 0.671 |
EEF2K |
0.616 | -0.037 | 3 | 0.658 |
TAK1 |
0.615 | -0.069 | 1 | 0.536 |
TTBK1 |
0.615 | -0.144 | 2 | 0.466 |
TNK2 |
0.615 | 0.148 | 3 | 0.657 |
BMPR1A |
0.614 | -0.063 | 1 | 0.541 |
GRK2 |
0.614 | -0.122 | -2 | 0.439 |
PKMYT1_TYR |
0.614 | 0.104 | 3 | 0.691 |
TESK1_TYR |
0.614 | 0.062 | 3 | 0.703 |
BIKE |
0.613 | 0.071 | 1 | 0.614 |
MST2 |
0.611 | -0.091 | 1 | 0.524 |
PDHK4_TYR |
0.611 | 0.065 | 2 | 0.726 |
MAP2K4_TYR |
0.610 | 0.044 | -1 | 0.682 |
RIPK2 |
0.609 | -0.145 | 1 | 0.460 |
MAP2K7_TYR |
0.606 | -0.039 | 2 | 0.683 |
LIMK1_TYR |
0.606 | 0.005 | 2 | 0.682 |
AAK1 |
0.606 | 0.096 | 1 | 0.549 |
TAO1 |
0.604 | -0.026 | 1 | 0.464 |
ABL1 |
0.603 | 0.047 | -1 | 0.641 |
MAP2K6_TYR |
0.603 | -0.030 | -1 | 0.669 |
TNK1 |
0.603 | 0.072 | 3 | 0.652 |
ABL2 |
0.602 | 0.044 | -1 | 0.633 |
PINK1_TYR |
0.602 | -0.105 | 1 | 0.629 |
MYO3A |
0.602 | -0.027 | 1 | 0.529 |
OSR1 |
0.602 | -0.033 | 2 | 0.682 |
GRK3 |
0.602 | -0.117 | -2 | 0.391 |
MST1 |
0.600 | -0.122 | 1 | 0.509 |
CK1A |
0.599 | -0.076 | -3 | 0.276 |
NEK10_TYR |
0.598 | 0.005 | 1 | 0.497 |
RET |
0.598 | -0.040 | 1 | 0.558 |
PDHK1_TYR |
0.598 | -0.089 | -1 | 0.659 |
TYRO3 |
0.597 | -0.008 | 3 | 0.659 |
EPHA6 |
0.597 | 0.028 | -1 | 0.640 |
ASK1 |
0.597 | -0.043 | 1 | 0.480 |
TNNI3K_TYR |
0.596 | 0.029 | 1 | 0.521 |
MST1R |
0.596 | -0.048 | 3 | 0.668 |
TXK |
0.595 | 0.072 | 1 | 0.618 |
BMPR2_TYR |
0.595 | -0.088 | -1 | 0.650 |
DDR1 |
0.595 | -0.025 | 4 | 0.663 |
BLK |
0.595 | 0.063 | -1 | 0.630 |
TYK2 |
0.595 | -0.081 | 1 | 0.551 |
ROS1 |
0.595 | -0.031 | 3 | 0.646 |
JAK2 |
0.594 | -0.060 | 1 | 0.526 |
LCK |
0.594 | 0.026 | -1 | 0.629 |
EPHB4 |
0.593 | 0.003 | -1 | 0.628 |
YANK3 |
0.593 | -0.057 | 2 | 0.292 |
TTK |
0.593 | -0.066 | -2 | 0.514 |
HCK |
0.593 | 0.000 | -1 | 0.636 |
JAK1 |
0.592 | 0.009 | 1 | 0.475 |
CSF1R |
0.592 | -0.043 | 3 | 0.671 |
YES1 |
0.592 | -0.030 | -1 | 0.669 |
PLK2 |
0.591 | -0.117 | -3 | 0.502 |
AXL |
0.590 | 0.015 | 3 | 0.646 |
FGR |
0.589 | -0.057 | 1 | 0.613 |
MERTK |
0.588 | 0.024 | 3 | 0.652 |
SRMS |
0.588 | -0.016 | 1 | 0.596 |
WEE1_TYR |
0.586 | -0.034 | -1 | 0.598 |
JAK3 |
0.585 | -0.073 | 1 | 0.548 |
KDR |
0.584 | -0.054 | 3 | 0.638 |
EPHB3 |
0.584 | -0.017 | -1 | 0.614 |
FER |
0.584 | -0.091 | 1 | 0.631 |
ITK |
0.584 | -0.022 | -1 | 0.634 |
EPHA4 |
0.581 | -0.054 | 2 | 0.604 |
EPHA1 |
0.581 | -0.008 | 3 | 0.640 |
ALPHAK3 |
0.581 | -0.127 | -1 | 0.561 |
BTK |
0.580 | -0.088 | -1 | 0.636 |
EPHB1 |
0.580 | -0.065 | 1 | 0.563 |
KIT |
0.580 | -0.087 | 3 | 0.655 |
TEC |
0.579 | -0.038 | -1 | 0.614 |
FLT3 |
0.578 | -0.134 | 3 | 0.657 |
TEK |
0.578 | -0.088 | 3 | 0.610 |
LYN |
0.578 | -0.036 | 3 | 0.603 |
FGFR2 |
0.578 | -0.104 | 3 | 0.637 |
PTK2B |
0.578 | -0.004 | -1 | 0.651 |
FYN |
0.577 | -0.027 | -1 | 0.598 |
PDGFRA |
0.577 | -0.137 | 3 | 0.666 |
CK1G3 |
0.576 | -0.087 | -3 | 0.242 |
DDR2 |
0.576 | -0.014 | 3 | 0.599 |
STLK3 |
0.576 | -0.127 | 1 | 0.471 |
PDGFRB |
0.576 | -0.147 | 3 | 0.653 |
BMX |
0.575 | -0.042 | -1 | 0.559 |
MET |
0.575 | -0.085 | 3 | 0.655 |
PTK6 |
0.575 | -0.120 | -1 | 0.597 |
EPHB2 |
0.575 | -0.066 | -1 | 0.605 |
LTK |
0.575 | -0.083 | 3 | 0.594 |
INSRR |
0.574 | -0.132 | 3 | 0.605 |
FGFR1 |
0.574 | -0.112 | 3 | 0.617 |
ALK |
0.574 | -0.100 | 3 | 0.569 |
EPHA7 |
0.574 | -0.047 | 2 | 0.609 |
FRK |
0.573 | -0.067 | -1 | 0.644 |
EPHA3 |
0.571 | -0.085 | 2 | 0.569 |
SRC |
0.569 | -0.058 | -1 | 0.617 |
MATK |
0.568 | -0.088 | -1 | 0.559 |
FLT1 |
0.568 | -0.136 | -1 | 0.582 |
NTRK1 |
0.566 | -0.166 | -1 | 0.607 |
NTRK3 |
0.565 | -0.108 | -1 | 0.559 |
FGFR3 |
0.565 | -0.129 | 3 | 0.614 |
ERBB2 |
0.564 | -0.155 | 1 | 0.517 |
YANK2 |
0.563 | -0.078 | 2 | 0.311 |
NTRK2 |
0.563 | -0.178 | 3 | 0.614 |
INSR |
0.563 | -0.137 | 3 | 0.604 |
CSK |
0.562 | -0.114 | 2 | 0.597 |
EPHA5 |
0.562 | -0.075 | 2 | 0.584 |
EPHA8 |
0.562 | -0.083 | -1 | 0.580 |
FLT4 |
0.562 | -0.161 | 3 | 0.631 |
MUSK |
0.561 | -0.088 | 1 | 0.478 |
PTK2 |
0.559 | -0.062 | -1 | 0.551 |
FGFR4 |
0.557 | -0.110 | -1 | 0.559 |
EGFR |
0.554 | -0.107 | 1 | 0.445 |
EPHA2 |
0.554 | -0.081 | -1 | 0.543 |
SYK |
0.548 | -0.108 | -1 | 0.509 |
ERBB4 |
0.548 | -0.077 | 1 | 0.468 |
CK1G2 |
0.547 | -0.104 | -3 | 0.301 |
FES |
0.546 | -0.096 | -1 | 0.552 |
ZAP70 |
0.543 | -0.049 | -1 | 0.468 |
IGF1R |
0.542 | -0.161 | 3 | 0.538 |